You are here

RECALL: Magnevist and Omniscan Solutions for injection

1 February, 2018
Recall

The Medicines and Healthcare Products Regulatory Agency have advised that Bayer plc and GE Healthcare AS are recalling batches of Magnevist Solution for injection, 0.5mmol/ml, intravenous and Omniscan Solutions for injection 0.5 mmol/ml.

The action follows a safety review of the gadolinium containing contrast media by the European Medicines Agency.

Class 2 Medicines Recall: Magnevist and Omniscan Solutions for injection EL (18) A/02

 

Content tools

Accessibility controls

Text size

AA A

Colour